Skip to main content
Clinical Trials/NCT01627145
NCT01627145UnknownNot Applicable

Post-treatment Normallized Urodynamic Findings as the Golden Standard of Objective Cure for Female Overactive Bladder Patients Receiving Antimuscarinic Drug and Its Correlations With Voiding Diary, King's Health Questionnaire, and Overactive Bladder Sympto

National Taiwan University Hospital1 site in 1 country300 target enrollmentStarted: August 2012Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Not Applicable
Enrollment
300
Locations
1
Primary Endpoint
The percentage of normalized urodynamic pattern after treatment

Study Overview

Brief Summary

Post-treatment Novmalized Urodynamiz Findings as the Golden Standard of Objective Cure for Female Overactive Bladder Patients Receiving Antimuscarinic Drug and Its Conelations With Voiding Diary, King's Health Quentionaire, Overactive Bladder Sympton Scores and Patient Perception of Bladder Condition.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • female patients within 18 years old to 99 years old with overactive bladder syndrome

Exclusion Criteria

  • unwilling or unable to perform testing procedure

Arms & Interventions

antimuscariniz drug

Experimental

Intervention: Solifenacin (Drug)

Outcomes

Primary Outcomes

The percentage of normalized urodynamic pattern after treatment

Time Frame: 12 weeks

Secondary Outcomes

  • The percentage of recurrence rates after treatment during follow-up and further to analyze the risk factors of recurrence(48 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

National Taiwan University Hospital

Professor, Department of Obstetrics & Gynecology

National Taiwan University Hospital

Study Sites (1)

Loading locations...

Similar Trials